William Blair analyst Andy Hsieh noted on Monday that Viking’s results surpassed Wall Street expectations and outperformed ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Novo Nordisk said the data on 10 deaths and more than 100 hospitalizations came from the US Food and Drug Administration’s ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

The past decade has seen the following events: The obesity and weight-loss drug market is expected to his $100 billion by ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs ...

Analysts expect the weight loss drug market to be worth more than $100 billion by the end of the decade as more treatments ...

Novo Nordisk has raised alarm about safety concerns related to compounded versions of its semaglutide-based drugs, Wegovy and Ozempic. The pharmaceuticals giant acknowledged reports of 10 deaths and ...